Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Attachment of ubiquitin to proteins represents a central mechanism for the regulation of protein metabolism and function. In the NF-kappaB pathway, binding of NEMO to polyubiquitinated substrates initiates the pathway in response to cellular stimuli. Other
polyubiquitin
binding proteins can antagonize this pathway by competing with NEMO for
polyubiquitin
. We have used protein arrays to identify
polyubiquitin
binding proteins that regulate NF-kappaB activity. Using
polyubiquitin
as bait, protein arrays were screened and
polyubiquitin
binders identified. Novel
polyubiquitin
binders AWP1, CALCOCO2, N4BP1, RIO3, TEX27, TTC3,
UBFD1
and ZNF313 were identified using this approach, while known NF-kappaB regulators including NEMO, A20, ABIN-1, ABIN-2, optineurin and p62 were also identified. Overexpressed AWP1 and RIO3 repressed NF-kappaB activity in a manner similar to optineurin, while siRNAs directed against AWP1 and RIO3 also reduced NF-kappaB activity. TNFalpha-dependent degradation of IkappaBalpha was also suppressed by overexpression of AWP1 and RIO3, possibly due to the
polyubiquitin
binding activity of these proteins. Protein array screening using
polyubiquitin
enabled rapid identification of many known and novel
polyubiquitin
binding proteins and the identification of novel NF-kappaB regulators.
...
PMID:Identification of polyubiquitin binding proteins involved in NF-kappaB signaling using protein arrays. 1928 59